Valeant Said to Be in Talks With Actavis on Merger

Valeant Pharmaceuticals International Inc. and Actavis Inc., two makers of generic drugs, have been in talks about a merger, people familiar with the matter said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.